FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2736280790> ?p ?o ?g. }

• W2736280790 abstract "The RV144 HIV vaccine trial included a recombinant HIV glycoprotein 120 (gp120) construct fused to a small portion of herpes simplex virus 1 (HSV-1) glycoprotein D (gD) so that the first 40 amino acids of gp120 were replaced by the signal sequence and the first 27 amino acids of the mature form of gD. This region of gD contains most of the binding site for HVEM, an HSV receptor important for virus infection of epithelial cells and lymphocytes. RV144 induced antibodies to HIV that were partially protective against infection, as well as antibodies to HSV. We derived monoclonal antibodies (MAbs) from peripheral blood B cells of recipients of the RV144 HIV vaccine and showed that these antibodies neutralized HSV-1 infection in cells expressing HVEM, but not the other major virus receptor, nectin-1. The MAbs mediated antibody-dependent cellular cytotoxicity (ADCC), and mice that received the MAbs and were then challenged by corneal inoculation with HSV-1 had reduced eye disease, shedding, and latent infection. To our knowledge, this is the first description of MAbs derived from human recipients of a vaccine that specifically target the HVEM binding site of gD. In summary, we found that monoclonal antibodies derived from humans vaccinated with the HVEM binding domain of HSV-1 gD (i) neutralized HSV-1 infection in a cell receptor-specific manner, (ii) mediated ADCC, and (iii) reduced ocular disease in virus-infected mice.IMPORTANCE Herpes simplex virus 1 (HSV-1) causes cold sores and neonatal herpes and is a leading cause of blindness. Despite many trials, no HSV vaccine has been approved. Nectin-1 and HVEM are the two major cellular receptors for HSV. These receptors are expressed at different levels in various tissues, and the role of each receptor in HSV pathogenesis is not well understood. We derived human monoclonal antibodies from persons who received the HIV RV144 vaccine that contained the HVEM binding domain of HSV-1 gD fused to HIV gp120. These antibodies were able to specifically neutralize HSV-1 infection in vitro via HVEM. Furthermore, we showed for the first time that HVEM-specific HSV-1 neutralizing antibodies protect mice from HSV-1 eye disease, indicating the critical role of HVEM in HSV-1 ocular infection." @default.
• W2736280790 created "2017-07-21" @default.
• W2736280790 creator A5002763808 @default.
• W2736280790 creator A5005978177 @default.
• W2736280790 creator A5024634769 @default.
• W2736280790 creator A5032122826 @default.
• W2736280790 creator A5034536696 @default.
• W2736280790 creator A5048749169 @default.
• W2736280790 creator A5051827275 @default.
• W2736280790 creator A5058440042 @default.
• W2736280790 creator A5062923881 @default.
• W2736280790 creator A5074973143 @default.
• W2736280790 creator A5076272996 @default.
• W2736280790 creator A5086589540 @default.
• W2736280790 creator A5089825041 @default.
• W2736280790 date "2017-10-01" @default.
• W2736280790 modified "2023-10-18" @default.
• W2736280790 title "Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1" @default.
• W2736280790 cites W1494969135 @default.
• W2736280790 cites W151663327 @default.
• W2736280790 cites W1529453182 @default.
• W2736280790 cites W1752010575 @default.
• W2736280790 cites W1753496995 @default.
• W2736280790 cites W1949254894 @default.
• W2736280790 cites W1970749005 @default.
• W2736280790 cites W1972143601 @default.
• W2736280790 cites W1976876715 @default.
• W2736280790 cites W1977243656 @default.
• W2736280790 cites W1980331452 @default.
• W2736280790 cites W1982277550 @default.
• W2736280790 cites W1985145726 @default.
• W2736280790 cites W1990209762 @default.
• W2736280790 cites W1995466180 @default.
• W2736280790 cites W2009600945 @default.
• W2736280790 cites W2009929706 @default.
• W2736280790 cites W2012456268 @default.
• W2736280790 cites W2015161652 @default.
• W2736280790 cites W2015912224 @default.
• W2736280790 cites W2016029960 @default.
• W2736280790 cites W2016268672 @default.
• W2736280790 cites W2022069273 @default.
• W2736280790 cites W2043074722 @default.
• W2736280790 cites W2048971587 @default.
• W2736280790 cites W2051181298 @default.
• W2736280790 cites W2052515157 @default.
• W2736280790 cites W2052855154 @default.
• W2736280790 cites W2055057051 @default.
• W2736280790 cites W2060119188 @default.
• W2736280790 cites W2068366518 @default.
• W2736280790 cites W2080492681 @default.
• W2736280790 cites W2082081016 @default.
• W2736280790 cites W2083201498 @default.
• W2736280790 cites W2088481447 @default.
• W2736280790 cites W2092939261 @default.
• W2736280790 cites W2103113343 @default.
• W2736280790 cites W2103863471 @default.
• W2736280790 cites W2105150633 @default.
• W2736280790 cites W2106059973 @default.
• W2736280790 cites W2109956845 @default.
• W2736280790 cites W2111252939 @default.
• W2736280790 cites W2113765407 @default.
• W2736280790 cites W2122667579 @default.
• W2736280790 cites W2123391493 @default.
• W2736280790 cites W2126153224 @default.
• W2736280790 cites W2128265967 @default.
• W2736280790 cites W2131356259 @default.
• W2736280790 cites W2131896393 @default.
• W2736280790 cites W2135151522 @default.
• W2736280790 cites W2142470167 @default.
• W2736280790 cites W2145134285 @default.
• W2736280790 cites W2146929518 @default.
• W2736280790 cites W2147132132 @default.
• W2736280790 cites W2148173142 @default.
• W2736280790 cites W2152048324 @default.
• W2736280790 cites W2154575731 @default.
• W2736280790 cites W2156805103 @default.
• W2736280790 cites W2161694144 @default.
• W2736280790 cites W2163537227 @default.
• W2736280790 cites W2165662544 @default.
• W2736280790 cites W2174957920 @default.
• W2736280790 cites W2233662553 @default.
• W2736280790 cites W2299295530 @default.
• W2736280790 cites W2346830803 @default.
• W2736280790 cites W2581244468 @default.
• W2736280790 cites W2606211905 @default.
• W2736280790 cites W2612825267 @default.
• W2736280790 cites W4230654908 @default.
• W2736280790 cites W73925412 @default.
• W2736280790 cites W85049179 @default.
• W2736280790 doi "https://doi.org/10.1128/jvi.00411-17" @default.
• W2736280790 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5599770" @default.
• W2736280790 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28701403" @default.
• W2736280790 hasPublicationYear "2017" @default.
• W2736280790 type Work @default.
• W2736280790 sameAs 2736280790 @default.
• W2736280790 citedByCount "18" @default.
• W2736280790 countsByYear W27362807902018 @default.
• W2736280790 countsByYear W27362807902019 @default.
• W2736280790 countsByYear W27362807902020 @default.
• W2736280790 countsByYear W27362807902021 @default.

• next